Moreover, by cross-comparing the results obtained from the Ramaswamy Multi-cancer Statistics using the online Oncomine tool (www.oncomine.org), we found that the expression of NCOA2 in breast cancer was relatively higher than that in other cancer types, including prostate cancer, bladder cancer, lung cancer, and lymphoma among others (Figure 1C) (30), suggesting an important role for NCOA2 in regulating breast cancer development. Here, NCOA2 is linked to lung carcinoma.